Brands and Their Owners
Welcome to the Brand page for “A-V IMPULSE SYSTEM”, which is offered here for Medical apparatus, an ex-vivo anatomical pump, impulse generator and controls therefor, sold as a unit, used for the reduction of post-operative and post-traumatic pain and swelling; for the reduction of compartmental pressures to avoid fasciotomy and associated complications; for pre-operative and post-operative prohylaxis of deep vein thrombosis; for the treatment of sudeck's syndrome (reflex sympathetic dystrophy); for maintaining patency and reducing edema in high-risk limb bypass grafts; i.e., femorodistal tibial graft; for a reduction in rest pain and maintenance of circulation in patients awaiting surgery; for the stimulation of circulation in peripheral vascular disease in the critically ischaemic limb to maintain limb viability; for the treatment of exacerbations of raynaud's disease; for the stimulation of circulation in patients at risk of developing ischaemic ulceration (diabetes, etc.); for the enhancement of blood supply prior to grafting; and for the treatment of venous ulceration and in the avoidance of recurrence.
Its status is currently believed to be dead. Its class is “Medical apparatus”. A-V IMPULSE SYSTEM is believed to have no current owner.
|Owner:||No Current Owner|
MEDICAL APPARATUS, AN EX-VIVO ANATOMICAL PUMP, IMPULSE GENERATOR AND CONTROLS THEREFOR, SOLD AS A UNIT, USED FOR THE REDUCTION OF POST-OPERATIVE AND POST-TRAUMATIC PAIN AND SWELLING; FOR THE REDUCTION OF COMPARTMENTAL PRESSURES TO AVOID FASCIOTOMY AND ASSOCIATED COMPLICATIONS; FOR PRE-OPERATIVE AND POST-OPERATIVE PROHYLAXIS OF DEEP VEIN THROMBOSIS; FOR THE TREATMENT OF SUDECK'S SYNDROME (REFLEX SYMPATHETIC DYSTROPHY); FOR MAINTAINING PATENCY AND REDUCING EDEMA IN HIGH-RISK LIMB BYPASS GRAFTS; I.E., FEMORODISTAL TIBIAL GRAFT; FOR A REDUCTION IN REST PAIN AND MAINTENANCE OF CIRCULATION IN PATIENTS AWAITING SURGERY; FOR THE STIMULATION OF CIRCULATION IN PERIPHERAL VASCULAR DISEASE IN THE CRITICALLY ISCHAEMIC LIMB TO MAINTAIN LIMB VIABILITY; FOR THE TREATMENT OF EXACERBATIONS OF RAYNAUD'S DISEASE; FOR THE STIMULATION OF CIRCULATION IN PATIENTS AT RISK OF DEVELOPING ISCHAEMIC ULCERATION (DIABETES, ETC.); FOR THE ENHANCEMENT OF BLOOD SUPPLY PRIOR TO GRAFTING; AND FOR THE TREATMENT OF VENOUS ULCERATION AND IN THE AVOIDANCE OF RECURRENCE